Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour ...

A flurry of deal-making hasn’t let up as 2025 comes to a close, with Roche subsidiary Genentech getting in on the action and ...

This new capability gives advertisers seamless access to the interactive ad format directly through their DSP of choice ...

New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocyt ...

Trump Media announces an all-stock merger with TAE Technologies, pivoting radically from media to fusion energy optionality.

We've ranked the most interesting archaeological finds of all time, ranging from the intricate ruins of Machu Picchu to the ...

The grace period is over. Twelve predictions on where AI creates value, breaks assumptions and triggers backlash as 2026 ...

AI will repeat whatever you teach it—a weakness your business can use to rank right away. Dale Carnegie would tell us that ...

Launched on 17 December 2025, the update followed the recent debut of GPT-5.2 and aimed to reclaim momentum from Google ...

Samsung Ads, the advertising division of Samsung Electronics, has announced the programmatic expansion of its interactive ad ...

The U.S. Space Force is looking for advanced technologies for space-based interceptors that can intercept ballistic missiles ...

In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for ...